Stockscreener 앱 받기
27.63
7.76%
1.99
시간 외 거래:
27.55
-0.08
-0.29%
전일 마감가:
$25.64
열려 있는:
$25.74
하루 거래량:
2.55M
Relative Volume:
2.08
시가총액:
$1.67B
수익:
$277.49M
순이익/손실:
$-192.14M
주가수익비율:
-8.2232
EPS:
-3.36
순현금흐름:
$-95.52M
1주 성능:
-8.54%
1개월 성능:
-27.35%
6개월 성능:
-40.19%
1년 성능:
-37.16%
1일 변동 폭
$25.50
$27.69
1주일 범위
$24.28
$31.20
52주 변동 폭
$24.28
$55.33
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
27.63 | 1.55B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
462.39 | 173.97B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.76 | 143.61B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.11 | 52.65B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.13 | 32.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
180.09 | 30.58B | 15.50B | 1.33B | 2.16B | 7.34 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
Improving Crop Resilience with AI and DNA Synthesis - the-scientist.com
After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST) - Nasdaq
Twist Bioscience’s DNA Ambitions Face Growth And Profit Hurdles - Finimize
Finn, Twist Bioscience COO, sells $90k in shares By Investing.com - Investing.com Nigeria
Cho Dennis, SVP at Twist Bioscience, sells $22k in shares - Investing.com Nigeria
Cho Dennis, SVP at Twist Bioscience, sells $22k in shares By Investing.com - Investing.com South Africa
Leproust, Twist Bioscience CEO, sells $158k in stock By Investing.com - Investing.com Canada
Finn, Twist Bioscience COO, sells $90k in shares - Investing.com India
Green Paula, SVP at Twist Bioscience, sells $35k in shares - Investing.com
Leproust, Twist Bioscience CEO, sells $158k in stock - Investing.com India
Werner, Twist Bioscience CAO, sells $5275 in TWST stock - Investing.com
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience stock hits 52-week low at 27.12 USD By Investing.com - Investing.com South Africa
Twist Bioscience stock hits 52-week low at 27.12 USD - Investing.com India
Twist Bioscience appoints Trynka Shineman Blake to board of directors - Investing.com
Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors - Business Wire
A Quick Look at Today's Ratings for Twist Bioscience(TWST.US), With a Forecast Between $25 to $46 - 富途牛牛
JPMorgan lowers Twist Bioscience stock price target to $25 from $33 - Investing.com
Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Can Traders Expect Breakout From Twist Bioscience Corporation This WeekEntry Zone Strategy for Consistent Profit Shared - metal.it
Twist Bioscience Corp SEC 10-Q Report - TradingView
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings - Benzinga
Twist Bioscience earnings beat by $0.86, revenue topped estimates - Investing.com
Twist Bioscience stock price target lowered to $36 by TD Cowen - Investing.com South Africa
Twist Bioscience: Fiscal Q3 Earnings Snapshot - The Washington Post
Evercore ISI lowers Twist Bioscience stock price target on revenue timing - Investing.com
Evercore ISI lowers Twist Bioscience stock price target on revenue timing By Investing.com - Investing.com South Africa
Twist Bioscience (TWST) Shares Drop 16.4% on Market Movements - GuruFocus
Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18% By Investing.com - Investing.com South Africa
Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18% - Investing.com Nigeria
Twist Bioscience (TWST) Q3 Profit Surges - The Motley Fool
Twist Bioscience (TWST) Q3 Profit Surges - Nasdaq
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - TradingView
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Q3 2025 slides: revenue hits $96.1M as margins exceed 50% target - Investing.com Canada
Will a bounce in Twist Bioscience Corporation offer an exitFree Real Time Alerts Based on AI Prediction - Newser
Using portfolio simulators with Twist Bioscience Corporation includedFree Stock Market Entry Timing Signals - Newser
Will Twist Bioscience Corporation benefit from macro trendsPredictive Model for Intraday Swing Forecast - Newser
What risks could impact Twist Bioscience Corporation stock performanceShort Squeeze Opportunities with Indicators - Newser
What catalysts could drive Twist Bioscience Corporation stock higher in 2025Maximize returns with data-driven strategies - Jammu Links News
Using Bollinger Bands to evaluate Twist Bioscience CorporationNeural Network Based Equity Prediction System - Newser
Twist Bioscience Corporation stock momentum explainedFree ROI Driven Equity Selection With Safety - Newser
What makes Twist Bioscience Corporation stock price move sharplyFinancial News Report For Fast Growth - Jammu Links News
Stocks in play: First Mining Gold Corp - The Globe and Mail
Twist Bioscience launches humanized transgenic mouse model By Investing.com - Investing.com Canada
Twist Bioscience launches humanized transgenic mouse model - Investing.com
Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model - Business Wire
What MACD and RSI say about Twist Bioscience CorporationExpert-Backed High Yield Stock Watchlist - Newser
Why Twist Bioscience Corporation stock attracts strong analyst attentionAsset Allocation Summary With Future Outlook - Newser
Using fundamentals and technicals on Twist Bioscience CorporationLong Term Stock Planner with Safety Checks - Newser
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
0.79%
자본화:
|
볼륨(24시간):